Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil

Abstract Background Inconsistent monitoring of prostate-specific antigen in patients receiving 5-alpha reductase inhibitors for lower urinary tract symptoms/benign prostate enlargement may affect prostate cancer outcomes. This study evaluated real-world practice among urologists treating patients re...

Description complète

Détails bibliographiques

Auteurs principaux:	Juan Manuel Palacios, Pratiksha Kapse, Vanessa Cortes, Marcio Augusto Averbeck, Alberto Budia Alba, Suryakant Somvanshi, Danilo Souza Lima da Costa Cruz, Fiona Pereira
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2025-01-01
Collection:	BMC Urology
Sujets:	5-alpha reductase inhibitors Benign prostatic hyperplasia Benign prostate enlargement Prostate-specific antigen Real-world data
Accès en ligne:	https://doi.org/10.1186/s12894-025-01701-1
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!